111 Capital Purchases New Holdings in Colgate-Palmolive Company $CL

111 Capital acquired a new position in Colgate-Palmolive Company (NYSE:CL) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 5,757 shares of the company’s stock, valued at approximately $460,000.

Several other large investors have also modified their holdings of CL. Westside Investment Management Inc. raised its holdings in shares of Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after acquiring an additional 130 shares in the last quarter. Copia Wealth Management purchased a new position in Colgate-Palmolive during the 3rd quarter valued at about $29,000. Vermillion & White Wealth Management Group LLC raised its holdings in shares of Colgate-Palmolive by 86.1% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after purchasing an additional 155 shares in the last quarter. Cloud Capital Management LLC purchased a new stake in shares of Colgate-Palmolive in the 3rd quarter worth approximately $30,000. Finally, MTM Investment Management LLC bought a new position in shares of Colgate-Palmolive during the second quarter valued at approximately $39,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Key Colgate-Palmolive News

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Colgate is expanding its AI push under Iraklis “Kli” Pappas to get employees using AI beyond basic tasks — a potential productivity and innovation catalyst that could help margin and SG&A efficiencies over time. The AI Evangelist Shaking Up a 220-Year-Old Toothpaste Maker
• Neutral Sentiment: NY Fed’s John Williams cautioned it’s too early to judge the Iran war’s economic impact — that leaves uncertainty about near‑term inflation and growth but does not yet force a clear re‑rating for defensive consumer names. Fed’s Williams: too early to assess Iran war impact on US economy
• Neutral Sentiment: Market strategists note the S&P reaction over the next few sessions will determine whether the sell‑off is transient; momentum there could affect broad multiples that support consumer staples valuations. History says this is the critical question for the S&P 500 over the next few days
• Negative Sentiment: Former Treasury Sec. Janet Yellen warned the Iran conflict could raise inflation and slow growth, making the Fed more reluctant to cut — a higher‑for‑longer rates backdrop can pressure defensive multiple expansion and consumer spending. Yellen says Iran conflict puts Fed on hold, complicates rate cuts
• Negative Sentiment: Analysts (UBS, Barclays) flag that the Iran escalation risks derailing several trades and raising credit/AI worries — the resulting risk‑off could reduce demand or margin flexibility for consumer packaged goods. Iran Conflict: Which trades & themes are most at risk? Iran escalation compounds AI and credit worries, Barclays’ Cau warns
• Negative Sentiment: Higher oil risk premia have pushed banks to lift targets for oil majors — good for energy names but a headwind for Colgate via higher packaging, freight and input costs if elevated oil persists. Chevron, Exxon price targets raised at BofA on increased oil risk premium

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $95.34 on Wednesday. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.54 and a current ratio of 0.83. The firm has a fifty day moving average of $88.16 and a 200 day moving average of $82.85. The firm has a market cap of $76.85 billion, a PE ratio of 36.39, a PEG ratio of 4.39 and a beta of 0.28. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $100.18.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The business had revenue of $5.23 billion during the quarter, compared to analyst estimates of $5.13 billion. During the same quarter in the prior year, the firm earned $0.91 earnings per share. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. As a group, research analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Wednesday, January 21st were paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio is presently 79.39%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the company. Bank of America raised their price objective on Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday, February 2nd. UBS Group raised their price target on Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a report on Wednesday, January 14th. Evercore boosted their price target on Colgate-Palmolive from $94.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, February 2nd. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $100.00 price objective on shares of Colgate-Palmolive in a research report on Friday, February 20th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Colgate-Palmolive from $93.00 to $97.00 and gave the stock an “overweight” rating in a research note on Monday, February 2nd. Eleven investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average target price of $94.75.

Insider Buying and Selling at Colgate-Palmolive

In other news, COO Panagiotis Tsourapas sold 15,000 shares of the business’s stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the completion of the sale, the chief operating officer owned 10,415 shares in the company, valued at approximately $1,018,691.15. The trade was a 59.02% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Stanley J. Sutula III sold 97,843 shares of the firm’s stock in a transaction dated Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total value of $9,223,659.61. Following the transaction, the chief financial officer directly owned 55,310 shares in the company, valued at approximately $5,214,073.70. The trade was a 63.89% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 184,683 shares of company stock valued at $17,486,693 in the last quarter. Corporate insiders own 0.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.